A Look at the Year in Generics

September 09, 2020

The generic pipeline continues to provide significant value to payers and patients as key products in top therapeutic classes lose patent protection.

Generic Drug Shortage Solutions on the Horizon

September 04, 2020

Pharmacy organizations stress that government initiatives must include an overall plan for drug pricing, payment model, and supply chain transparency.

To “Buy American” Generic Drugs, Pharmacists Must Be Adequately Reimbursed

August 20, 2020

Why do we pharmacists buy generics from foreign manufacturers? The answer is pure and simple: the cost.

Mylan Launches Generic Version of Multiple Sclerosis Treatment

August 20, 2020

Mylan has launched the first FDA-approved generic version of Biogen’s dimethyl fumarate (Tecfidera) for relapsing forms of multiple sclerosis.

The Pharmacist’s Role in Generic Substitution

August 10, 2020

Pharmacists are in a unique position to recommend cost-saving generics and counsel patients on generic substitution.

Study Compares Cost, Accessibility of Novel Cancer Drugs in US and India

August 07, 2020

The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.

Sandoz to Supply Critical Injectable Generic Medications to Hospitals

July 14, 2020

Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.

Out-of-Pocket Costs Declined for Generic Drugs Available Through Discount Programs

July 13, 2020

Medicare beneficiary out-of-pocket costs for generic drugs used to treat chronic conditions declined from 2009 to 2017.

Coronavirus News Roundup: Vaccine Trials Gaining Momentum, Pharmacists Fight Racism Amid COVID-19

June 26, 2020

Check out this week's most important coronavirus-related news.

Demand for Generic Steroid Spikes After Preliminary COVID-19 Results

June 25, 2020

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

Study: Patient Perceptions of Safety, Efficacy Not Swayed by Generic Drug Appearances

June 12, 2020

Survey respondents contradicted prior research that has suggested that manufacturer changes in medication appearance affect perceptions of safety and effectiveness.

ASCO20: Switching to Generic Bortezomib Can Yield Significant Cost Savings

June 03, 2020

The study’s authors examined the opportunity to decrease the overall cost of bortezomib by $300-400 million by switching patients to the generic version.

Barriers Coming Down for Complex Generic Drug Products

April 14, 2020

This year may mark a dramatic difference in the development and approval of complex generic drug products.

Generic Ziprasidone Mesylate for Injection Now Available in United States

March 18, 2020

Dr. Reddy’s Laboratories has launched its ziprasidone mesylate 20 mg/mL for injection, the first generic version of Geodon (Pfizer) for injection. 

California Considering Its Own Generic Drug Label

January 29, 2020

A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.

The Impact of Patents and Exclusivities on FDA’s Approval of Generic Drugs

January 07, 2020

What are some of the factors affecting whether a brand-name drug has generic competition?

Medicare Prescription Plans May Take Longer to Cover New Generic Drugs

December 05, 2019

Pharmacists can help advocate for availability and coverage.

What Pharmacists Should Know About the FDA’s DCAP for Generic Drug Access

December 05, 2019

Removing patient barriers to generic drugs.

Generic Drug Pricing Trends

November 05, 2019

Savings totaled $293 billion in 2018.

Generic Drugs 101: What Pharmacists Need to Know

November 05, 2019

Abbreviated New Drug Applications, state laws, and more.